Regulus Resources Inc. (“Regulus” or the “Company”, TSX-V: REG, OTCQX: RGLSF) announces that it has adopted a shareholder rights plan (the “Rights Plan ”) effective as of March 30, 2026, pursuant to a ...

Who is Chris Bledsoe? Explore his encounters with mysterious orbs, reported government interest, and his prediction that a ...

The article details the celestial configuration of the waning Moon and Regulus in the constellation Leo for observation on October 15. Regulus is identified as a magnitude 1.4, quadruple-star system, ...

Regulus will suddenly disappear from view for a couple of hours on the first evening of British summer time ...

Novartis has agreed to acquire US-based Regulus Therapeutics and its oligonucleotide, farabursen, to bolster its renal disease offerings. The upfront cash payment represents a significant premium over ...

Forbes contributors publish independent expert analyses and insights. An award-winning reporter writing about stargazing and the night sky. This weekend, a beautiful crescent moon will dominate the ...

Every investor in Regulus Therapeutics Inc. (NASDAQ:RGLS) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 48% to be precise, ...

Shares of Regulus Therapeutics (NASDAQ:RGLS) spiked on Thursday after the microRNA-focused drug developer announced additional topline data from a Phase 1b trial for its lead asset, farabursen, ...

This is “Looking UP! in southern Colorado,” from the Colorado Springs Astronomical Society. I’m Hal Bidlack, and there are lots of reasons to look up! As you look up in the southern Colorado sky, did ...

Novartis AG has agreed to buy U.S. biotech firm Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash up-front through a ...